MedComm – Oncology (Dec 2023)
Systematic analysis of markers for T‐cell differentiation revealing CD95 as a novel biomarker for prognosis and immunotherapeutic efficacy in colon cancer
Abstract
No abstracts available.
MedComm – Oncology (Dec 2023)